Archive: Patient Engagement

3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments.

Posted: May 30th, 2024

Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs.

Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest.

Author: parexcel
Posted: September 8th, 2022

Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population

Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic.

Author: parexcel
Posted: May 28th, 2022

At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was

Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression.

Author: parexcel
Posted: March 31st, 2022

In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes

How to Boost Patient Engagement for Cervical Cancer Clinical Trials

Posted: January 8th, 2020

For Cervical Cancer Awareness Month, we examine how adopting a patient-centric approach can improve clinical trial experiences for cervical cancer patients.

How Sponsors and CROs Can Build Patient Trust in Clinical Trials

Posted: December 12th, 2019

By prioritizing informational content and embracing social media, sponsors and CROs can build lasting connections with patients.

Report: Receiving Clinical Trial Results Makes Patients More Likely to Participate

Posted: January 30th, 2019

A recent study reveals that sharing clinical trial results with patients can help boost trial participation and engagement.

4 Patient-Centric Clinical Trial Trends for 2019

Posted: January 16th, 2019

2019 is the year of the patient. Here’s how CROs and sponsors can tap into patient-centric models to improve trial recruitment and retention.

How eConsent Is Changing Clinical Trials

Author: tdower
Posted: July 25th, 2018

With increased convenience and a more streamlined flow of information, eConsent offers benefits for patients and clinical trial investigator sites alike.

Have Clinical Trials Achieved Patient Engagement?

Posted: May 16th, 2018

A recent study shows that, while there is still progress to be made, clinical trials are implementing new tools to boost patient engagement.